TR200201440T2 - Biomedikal kullanım için radyum-223 hazırlanması - Google Patents

Biomedikal kullanım için radyum-223 hazırlanması

Info

Publication number
TR200201440T2
TR200201440T2 TR2002/01440T TR200201440T TR200201440T2 TR 200201440 T2 TR200201440 T2 TR 200201440T2 TR 2002/01440 T TR2002/01440 T TR 2002/01440T TR 200201440 T TR200201440 T TR 200201440T TR 200201440 T2 TR200201440 T2 TR 200201440T2
Authority
TR
Turkey
Prior art keywords
radium
preparation
biomedical use
bone
treatment
Prior art date
Application number
TR2002/01440T
Other languages
English (en)
Turkish (tr)
Inventor
H. Larsen Roy
Henriksen Gjermund
Original Assignee
Anti-Cancer Therapeutic Inventions As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anti-Cancer Therapeutic Inventions As filed Critical Anti-Cancer Therapeutic Inventions As
Publication of TR200201440T2 publication Critical patent/TR200201440T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
TR2002/01440T 1999-01-04 1999-12-17 Biomedikal kullanım için radyum-223 hazırlanması TR200201440T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO990001A NO310544B1 (no) 1999-01-04 1999-01-04 Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben

Publications (1)

Publication Number Publication Date
TR200201440T2 true TR200201440T2 (tr) 2002-08-21

Family

ID=19902803

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2002/01440T TR200201440T2 (tr) 1999-01-04 1999-12-17 Biomedikal kullanım için radyum-223 hazırlanması
TR2001/02707T TR200102707T2 (tr) 1999-01-04 1999-12-17 AĞrì hafifletme, kemik kanseri terapisi ve kemik yzeyinin saĞlìklì tutulmasì i‡in kire‡lenmiç hedef dokulara y”nelik radyum-223 hazìrlanmasì ve kullanìmì.
TR2002/01442T TR200201442T2 (tr) 1999-01-04 1999-12-17 Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı.

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2001/02707T TR200102707T2 (tr) 1999-01-04 1999-12-17 AĞrì hafifletme, kemik kanseri terapisi ve kemik yzeyinin saĞlìklì tutulmasì i‡in kire‡lenmiç hedef dokulara y”nelik radyum-223 hazìrlanmasì ve kullanìmì.
TR2002/01442T TR200201442T2 (tr) 1999-01-04 1999-12-17 Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı.

Country Status (24)

Country Link
US (2) US6635234B1 (enExample)
EP (1) EP1140212B1 (enExample)
JP (2) JP4649044B2 (enExample)
KR (1) KR100671387B1 (enExample)
CN (2) CN1767078B (enExample)
AT (1) ATE331534T1 (enExample)
AU (1) AU774991B2 (enExample)
BE (1) BE2014C028I2 (enExample)
BR (1) BR9916768A (enExample)
CA (1) CA2358498C (enExample)
CY (2) CY1105634T1 (enExample)
DE (1) DE69932183T2 (enExample)
DK (1) DK1140212T3 (enExample)
EA (1) EA003496B1 (enExample)
ES (1) ES2268888T3 (enExample)
IL (1) IL144135A0 (enExample)
LU (1) LU92425I2 (enExample)
MX (1) MXPA01006823A (enExample)
NO (2) NO310544B1 (enExample)
NZ (3) NZ534618A (enExample)
PT (1) PT1140212E (enExample)
TR (3) TR200201440T2 (enExample)
WO (1) WO2000040275A2 (enExample)
ZA (1) ZA200105431B (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
AUPQ923100A0 (en) * 2000-08-07 2000-08-31 Peplin Research Pty Ltd Treatment of prostate cancer
EP1469860A4 (en) * 2002-01-24 2005-09-07 Yissum Res Dev Co ANTICANCER COMBINATION AND USE THEREOF
GB0213261D0 (en) * 2002-06-10 2002-07-17 Anticancer Therapeutic Inv Sa Method
GB0308731D0 (en) * 2003-04-15 2003-05-21 Anticancer Therapeutic Inv Sa Method of radiotherapy
US8894969B2 (en) 2003-04-30 2014-11-25 Althera Medical Ltd. Method and device for radiotherapy
EP1735013B1 (en) * 2004-02-20 2012-02-08 Algeta ASA Alpha- and beta-emitting hydroxyapatite particles
DE102004022200B4 (de) * 2004-05-05 2006-07-20 Actinium Pharmaceuticals, Inc. Radium-Target sowie Verfahren zu seiner Herstellung
US7914766B1 (en) * 2004-06-03 2011-03-29 Ut-Battelle Llc Inorganic resins for clinical use of 213Bi generators
GB0423565D0 (en) * 2004-10-22 2004-11-24 Algeta As Formulation
EP1909855B8 (en) * 2005-07-26 2019-03-20 Aplha TAU Medical Ltd. A radioactive surface source and a method for producing the same
US8709380B1 (en) * 2006-02-07 2014-04-29 Sirius Medicine, Llc Targeting agents for enhancing radiation therapy
DE102006008023B4 (de) * 2006-02-21 2008-05-29 Actinium Pharmaceuticals, Inc. Verfahren zum Reinigen von 225Ac aus bestrahlten 226Ra-Targets
CA2950532C (en) * 2006-09-08 2018-10-23 Actinium Pharmaceuticals, Inc. Method for the purification of radium from different sources
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
GB201007353D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
WO2014095833A1 (en) 2012-12-19 2014-06-26 Bayer Pharma Aktiengesellschaft Combination comprising radium-223 for the treatment of cancer
GB201314718D0 (en) * 2013-08-16 2013-10-02 Algeta As Quantification method
CA2932221C (en) 2013-12-03 2022-02-22 Bayer Pharma Aktiengesellschaft Combination of pi3k-inhibitors
EP3077003A1 (en) 2013-12-03 2016-10-12 Bayer Pharma Aktiengesellschaft Combination of pi3k-inhibitors
TW201607538A (zh) 2013-12-17 2016-03-01 以斯提夫博士實驗室股份有限公司 血清素－去甲腎上腺素再攝取抑制劑（ＳＮＲＩＳ）和σ受體配體組合物
WO2016083739A1 (fr) 2014-11-26 2016-06-02 Rhodia Operations Composition de lanthane et d'actinium-227
GB201600153D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
GB201600154D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
CZ307369B6 (cs) * 2016-12-22 2018-07-04 České vysoké učení technické v Praze Kombinace pro radionuklidovou terapii pro použití jako léčivo
AR110995A1 (es) 2017-02-24 2019-05-22 Bayer Ag Combinación de inhibidores de quinasa atr con sal de radio-223
WO2018207105A1 (en) 2017-05-11 2018-11-15 Alpha Tau Medical Ltd. Polymer coatings for brachytherapy devices
KR102715288B1 (ko) 2018-04-02 2024-10-11 알파 타우 메디컬 리미티드 방사성 핵종의 제어된 방출
EP3563875A1 (en) * 2018-05-04 2019-11-06 Ceské vysoké ucení technické v Praze Radium for radionuclide therapy, in combination with calcium metabolism affecting treatment
LU100900B1 (de) * 2018-08-10 2020-02-17 Thomas Melchior Homann Verbindungen zur modulation von a-ketoglutarsäure (2kg)-abhängigen oxygenasen
FR3086186B1 (fr) * 2018-09-26 2022-01-28 Orano Med Procede de production de plomb-212 a partir d'une solution aqueuse comprenant du thorium-228 et ses descendants
FR3088769B1 (fr) * 2018-11-15 2020-12-25 Orano Med Procede de preparation d'au moins un generateur a haute teneur en radium-228
US20220152228A1 (en) * 2019-03-01 2022-05-19 Washington University Compositions and methods for radiotherapy using chelated radiotherapeutic agents and non-target tissue blockade
CN114902350A (zh) 2019-12-05 2022-08-12 塞控斯公司 生产高纯度212Pb
RU2752845C1 (ru) * 2020-05-13 2021-08-11 Акционерное Общество "Наука И Инновации" Способ получения высокочистого радия-223
EP4262888A4 (en) * 2020-12-16 2024-10-30 Alpha Tau Medical Ltd. DIFFUSION ALPHA-EMITTER RADIATION THERAPY WITH IMPROVED BETA TREATMENT
CN113066598B (zh) * 2021-03-25 2023-08-08 中国科学院近代物理研究所 一种从高能质子束辐照232Th靶引起的散裂反应中分离纯化223Ra的方法
US12076582B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for colorectal cancer
US12064643B2 (en) 2021-06-10 2024-08-20 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for breast cancer
US12070620B2 (en) 2021-06-10 2024-08-27 Alpha Tau Medical Ltd. Activity levels for diffusing alpha-emitter radiation therapy
US12076583B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for melanoma
US12076581B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for glioblastoma
US12042668B2 (en) 2021-06-10 2024-07-23 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for squamous cell carcinoma
US12070621B2 (en) 2021-06-10 2024-08-27 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for pancreatic cancer
US11964168B2 (en) 2021-06-10 2024-04-23 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for prostate cancer
CA3252487A1 (en) 2022-02-21 2023-08-24 Bayer Healthcare Llc SYSTEM, METHOD AND DEVICE FOR ADMINISTERING A THERAPEUTIC OR DIAGNOSTIC AGENT
AU2023221437A1 (en) 2022-02-21 2024-08-22 Bayer Healthcare Llc System, method and device for delivery of a therapeutic or diagnostic agent.
CN115869658B (zh) * 2022-12-29 2025-01-28 中国核动力研究设计院 用于制备Ra-223的分离系统及其分离方法、应用和制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH668489A5 (de) * 1982-01-22 1988-12-30 Vnii Mineralnogo Syrya Radiometrisches verfahren zur bestimmung der konzentration natuerlicher radiumisotope und einrichtung zur durchfuehrung des verfahrens.
WO1990003803A1 (en) * 1988-10-14 1990-04-19 Mallinckrodt, Inc. Radiolabelled particulate composition
US4970062A (en) * 1989-05-30 1990-11-13 The United States Of America As Represented By The United States Department Of Energy Colloid labelled with radionuclide and method
CA2123588A1 (en) * 1991-11-14 1993-05-27 Frederick C. Leung Method for diagnosing and treating cancer
CA2163107C (en) * 1993-05-17 2001-04-17 David Milton Goldenberg Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
US5809394A (en) * 1996-12-13 1998-09-15 Battelle Memorial Institute Methods of separating short half-life radionuclides from a mixture of radionuclides
US6117413A (en) * 1997-11-12 2000-09-12 Battelle Memorial Institute Radionuclide-binding compound, a radionuclide delivery system, a method of making a radium complexing compound, a method of extracting a radionuclide, and a method of delivering a radionuclide
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
GB0213261D0 (en) * 2002-06-10 2002-07-17 Anticancer Therapeutic Inv Sa Method
GB0308731D0 (en) * 2003-04-15 2003-05-21 Anticancer Therapeutic Inv Sa Method of radiotherapy
US20060228297A1 (en) * 2003-04-15 2006-10-12 Roy Larsen Thorium-227 for use in radiotherapy of soft tissue disease

Also Published As

Publication number Publication date
US20030206857A1 (en) 2003-11-06
CN1767078B (zh) 2012-01-11
CA2358498C (en) 2008-09-16
NO2014010I2 (enExample) 2014-05-09
NZ534618A (en) 2006-03-31
LU92425I2 (fr) 2014-06-10
TR200102707T2 (tr) 2002-03-21
CA2358498A1 (en) 2000-07-13
AU774991B2 (en) 2004-07-15
CY2014020I1 (el) 2015-12-09
US6635234B1 (en) 2003-10-21
DK1140212T3 (da) 2006-10-09
DE69932183T2 (de) 2007-05-16
NO990001D0 (no) 1999-01-04
JP4649044B2 (ja) 2011-03-09
NZ545023A (en) 2007-08-31
TR200201442T2 (tr) 2002-08-21
EP1140212A2 (en) 2001-10-10
CN1767078A (zh) 2006-05-03
PT1140212E (pt) 2006-11-30
CY1105634T1 (el) 2010-12-22
JP5433490B2 (ja) 2014-03-05
NO310544B1 (no) 2001-07-23
BE2014C028I2 (enExample) 2019-03-05
NO2014010I1 (no) 2014-06-02
CN1335779A (zh) 2002-02-13
CN1194764C (zh) 2005-03-30
AU1700400A (en) 2000-07-24
EA200100642A1 (ru) 2002-02-28
WO2000040275A3 (en) 2001-06-21
ZA200105431B (en) 2002-07-02
EP1140212B1 (en) 2006-06-28
HK1090750A1 (en) 2006-12-29
IL144135A0 (en) 2002-05-23
ATE331534T1 (de) 2006-07-15
KR100671387B1 (ko) 2007-01-19
JP2010168397A (ja) 2010-08-05
EA003496B1 (ru) 2003-06-26
DE69932183D1 (de) 2006-08-10
CY2014020I2 (el) 2015-12-09
BR9916768A (pt) 2001-12-04
JP2002534399A (ja) 2002-10-15
WO2000040275A2 (en) 2000-07-13
KR20010092772A (ko) 2001-10-26
MXPA01006823A (es) 2003-07-14
ES2268888T3 (es) 2007-03-16
NO990001L (no) 2000-07-05
NZ513135A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
TR200201440T2 (tr) Biomedikal kullanım için radyum-223 hazırlanması
MXPA03006771A (es) Anticuerpos modificados y metodos de uso.
CA2403687A1 (en) Surgical articles
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
FR2721198B1 (fr) Prothèse implantable souple, utilisée en chirurgie pour l'augmentation de volume ou la reconstruction des tissus mous, notamment prothèse mammaire.
WO2002041837A3 (en) Treatment of mucositis
AU5338301A (en) Methods and compositions for modulating alpha adrenergic receptor activity
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
AU1866801A (en) Bioactive sol-gel derived silica fibers, methods for their preparation and theiruse
MY164077A (en) Compositions and uses of et743 for treating cancer
HK1047707A1 (zh) (+)-曲马朵、o-去甲曲马朵或(+)-o-去甲曲马朵、o-去甲-n-单-去甲-曲马朵或(+)-o-去甲-n-单-去甲-曲马朵治疗尿失禁的用途
EP1162956B8 (en) Compositions and methods for improving integrity of compromised body passageways and cavities
PT1255538E (pt) Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
WO2000078800A3 (en) Combined decorin binding protein and outer surface protein compositions and methods of use
AU2002319223A1 (en) Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
WO2004075977A3 (en) Methods using diffuse field ultrasound-induced hyperthermia
UA32315A (uk) Спосіб накладання шкірного шва
UA32302A (uk) Спосіб усунення післяопераційних деформацій м'яких тканин
NO984965D0 (no) Komponent B som cicatrisant
DE69614577D1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
GB9723824D0 (en) Cytostatic agents
SI1196159T1 (en) Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
UA33331A (uk) Спосіб профілактики гнійно-септичних ускладнень в післяопераційному періоді
UA32174A (uk) Спосіб хірургічного лікування гемангіом надбровної області